Invega Hafyera (paliperidone palmitate) for schizophrenia is given once every 6 months. Your starting dosage depends on the strength of your most recent dose of other injectable forms of the drug.

Invega Hafyera is a brand-name extended-release injection that’s prescribed for schizophrenia. Invega Hafyera contains the active ingredient paliperidone palmitate and belongs to the antipsychotic ...

Invega Sustenna (paliperidone palmitate) is a prescription drug that’s used to treat schizophrenia and schizoaffective disorder. Invega Sustenna is given as an injection into your muscle by a ...

PRINCETON, N.J., April 6, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI® (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in ...

PRINCETON, N.J., July 28, 2024 /PRNewswire/ -- Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sales of innovative medications, today ...